Copyright
©The Author(s) 2020.
World J Stem Cells. Nov 26, 2020; 12(11): 1255-1275
Published online Nov 26, 2020. doi: 10.4252/wjsc.v12.i11.1255
Published online Nov 26, 2020. doi: 10.4252/wjsc.v12.i11.1255
Species | Tendon(s) | Groups | Duration of DM | Biomechanical properties of diabetic tendons | Ref. |
Human | Achilles tendon | CG and DG | An average of 14 yr | Significantly less tendon elongation, higher tendon stiffness and hysteresis, and lower tendon forces in DM group during walking compared with CG. | Petrovic et al[23], 2018 |
Human | Achilles tendon | CG and DG | An average of 13 yr | No significance in maximum force including max force, stiffness, stress, strain, and modulus between DG and CG, but a trend towards reduced tendon strain in DG; significantly higher tendon modulus in common force in DG than in CG. | Couppé et al[24], 2016 |
Human | Achilles tendon | CG and DG | Stage V type II diabetes patients | Significantly inferior biomechanical properties of diabetic tendons in DG including decreased elasticity (Young′s modulus), maximum load, stiffness, toughness, load at yield point, energy, strain, and elongation at break point, tenacity, and strain at automatic load drop. | Guney et al[17], 2015 |
Human | Achilles tendon | CG, DG I (with foot ulcer), and DG II (without foot ulcer). | An average of 15 yr in DG I and an average of 6 yr in DG II. | Significantly higher thickness of proximal, medial, and distal third tendon in DG I than in DG II and CG, higher tendon thickness in DG II than in CG but no significance; significantly reduced stiffness of medial and distal third tendon in DG I. | Evranos et al[22], 2015 |
Male C57Bl/6J mice | FDL tendon | CG (low fat diet) and DM (high fat diet) | High or low-fat diet for 48 wk; at 12, 24, and 48 d post-injury. | Significantly decreased tendon range of motion at 40 and 48 wk in high fat diet group relative to low fat diet group; reduced max load at failure at 48 wk and increased stiffness at 24 wk in high fat diet group. | Studentsova et al[30], 2018 |
Male C57Bl/6J mice | FDL tendon | CG (low fat diet) and DM (high fat diet) | High or low-fat diet for 12 wk; at 10, 14, 21, and 28 d post-diet initiation. | Significantly lower maximum load, yield load, and energy to maximum force of tendon in DM compared with CG at 28 d; no differences in stiffness between the two groups. | Ackerman et al[31], 2017 |
Male C57BL/KsJ (db/db) mice | Achilles tendon | CG and DG | 16 wk of DM | Significantly decreased maximum load, elastic modulus, maximum stress, and stiffness of tendons in DG; no significance in tensile strain. | Boivin et al[16], 2014 |
db/db Diabetic mice and db/+ non-diabetic heterozygous control mice | Supraspinatus, Achilles, and patellar tendons. | CG and DG | 60 days for DM | Significantly reduced stiffness at the insertion site of tendons in DG for all three tendons and reduced modulus at the insertion site of Achilles tendons in DG; no significance in stiffness or modulus of mid-substance in any tendon between DG and CG. | Connizzo et al[33], 2014 |
Male C57BL/6J mice | FDL tendon | CG (low fat diet) and DG (high fat diet) | High or low-fat diet for 12 wk for uninjured tendons; high or low-fat diet for 24 wk for injured tendons, at 7, 14, and 28 d post-injury. | No significance in biomechanical parameters including maximum force, work to maximum force, and stiffness of uninjured FDL tendon at 12 wk; reduced maximum force of uninjured FDL tendon at 24 wk; significantly decreased biomechanical parameters of injured tendons in DG at 28 d. | David et al[32], 2014 |
Wistar rats | Achilles tendon | CG and DG | 4 wk post-induction; 3 wk post-operation. | No significance in ultimate load, ultimate elongation, stiffness, ultimate strength, ultimate strain, elastic modulus, and cross-sectional area. | de Oliveira et al[36], 2019 |
Wistar rats | Achilles tendon | CG and DG | 5 wk post-induction | Significantly increased elastic modulus and maximum tension, reduced transverse area in DG; no significance in maximum strength between DG and CG. | Bezerra et al[27], 2016 |
SD rats | Achilles and tail tendon | CG, acute DG (1 wk), and chronic DG (10 wk) | 10 wk post-induction | No significance in biomechanical properties of Achilles and tail tendons between groups, including maximum force, deformation, stiffness, stress, strain, and Young’s modulus. | Volper et al[12], 2015 |
Wistar rats | Achilles tendon | CG and DG | 30 d post-induction; at days 10 post-surgery. | Significantly decreased stress tensile load and Young's modulus of stiffness of tendons in DG than in CG. | Mohsenifar et al[20], 2014 |
ZDSD and control rats (CD: SD-derived) | Tail tendon | CG and DG | High fat diet for 12 wk | Significantly higher nanoscale modulus at tendon fibrils level in DG and more variable compared with CG; at the fascicle level, no significance in mechanical properties between DG and CG; at the material level, significantly greater ultimate stress and modulus in DG tendon than in CG. | Gonzalez et al[28], 2014 |
SD rats | Supraspinatus tendon | Hyperglycemia group and control group | 8 wk following hyperglycemia induction | No significance in stiffness and modulus at both the insertion site and mid-substance of tendon between hyperglycemia group and control group. | Thomas et al[35], 2014 |
Lewis rats | Achilles tendon | CG and DG | 5 d post-induction | Significantly reduced maximum tensile load of tendon in DG. | Lehner et al[19], 2012 |
Male diabetic GK rats and control Wistar rats | Achilles tendon | CG and DG | 1 year of DM; at 14 d post-rupture. | No significance in biomechanical properties as peak load, energy at peak load and stress, except for lower stiffness of intact tendons in DG; lower stiffness of injured tendons in DG compared with the injured tendons in CG. | Ahmed et al[21], 2012 |
Wistar rats | Achilles tendon | CG and DG | 70 d post-induction | Significantly decreased elastic modulus of tendon in DG; increased specific deformation, deformation at maximum force and energy/tendon area of tendon in DG. | de Oliveira et al[26], 2012 |
Wistar rats | Achilles tendon | CG and DG | 70 d post-induction | Significantly decreased elastic modulus of tendon in DG; increased specific strain, maximum strain and energy/tendon area of tendon in DG. | de Oliveira et al[25], 2011 |
Lewis rats | Patellar tendon | CG and DG | 12- and 19-d post-induction | Significantly reduced Young′s modulus of tendon in DG at both time points. | Fox et al[15], 2011 |
Lewis rats | Supraspinatus tendon | CG and DG | 1 and 2 wk post-operation | Significantly reduced mean load-to-failure and stiffness of tendon-bone complex in DG at both time points. | Bedi et al[34], 2010 |
New Zealand rabbits | Achilles tendon | Non-glycated group and glycated group | 60 d following glycation | Significant increase in maximum load, Young′s modulus of elasticity, energy to yield, and toughness of glycated tendon. | Reddy et al[29], 2003 |
Species model | Tendon(s) | Groups | Duration of DM | Histopathological feature of diabetic tendons | Ref. |
Human | Achilles tendons | CG and DG | Stage V diabetes patients | Diabetic tendons had mild impairment of collagen organization and focal collagen degeneration. | Guney et al[17], 2015 |
Human | Stenosing flexor tenosynovitis | CG and DG | DM for an average of 17 yr | SFTS in diabetic patients had fibrocartilage metaplasia including fibrocartilage-like cells, and granulation tissue contained newly formed microvessels stromal cells, a small number of inflammatory cells, and extracellular matrix that showed myxomatous degeneration. | Kameyama et al[18], 2013 |
Human | Rotator cuff tendon | CG and DG | DM for at least 5 yr | IHC showed increased MMP-9 and IL-6 in the torn tendon of diabetic patients. | Chung et al[46], 2017 |
Male C57Bl/6J mice | FDL tendons | CG (low fat diet) and DG (high fat diet) | At 40 wk post-induction | Lipid deposits were observed in the mid-substance of high fat diet-induced diabetic tendons. | Studentsova et al[30], 2018 |
C57BL/6 mice | Achilles tendons | CG and DG | DM for one-year post-induction | Fiber disorganization, uneven glycoprotein deposition, and increased interfibrillar spaces in diabetic tendon. | Wu et al[39], 2017 |
Male db/db C57BL/KsJ mice and wild type control C57BL/6 mice. | Achilles tendons | CG and DG | DM for 11 wk | Mild neutrophil infiltration, mild disorganization of the collagen fibers, mild increased basophilia of the tenocytes, and mildly increased nuclear size/rounding were observed in diabetic tendon. These pathologic changes are consistent with degenerative tendon. | Boivin et al[16], 2014 |
C57BL/6J Ob mice and wild-type mice | Achilles tendons | CG and DG (obese group, leptin-deficient) | 12 wk | In diabetic Achilles tendon, some collagen fibers separated and lost their parallel orientation, with a decrease in fiber diameter and in density of collagen. Unequal and irregular crimping, loosening, increased waviness, lots of degeneration of tendon cells and chondrocyte-like cells were observed. Otherwise, diabetic tendons also showed obvious ruptures in insertion area, degeneration of tendinocytes, collagen fibers microtears, and vascular proliferation. | Ji et al[38], 2010 |
Male C57Bl/6J mice | FDL tendon | CG (low fat diet) and DG (high fat diet) | Surgery at 12 wk post-induction; days 7-28 post-repair. | After surgical transection injury, the diabetic tendons induced by high fat diet exhibited excess and prolonged scar tissue formation. | Ackerman et al[31], 2017 |
Male C57BL/6 mice | FDL tendons | CG (low fat diet) and DG (high fat diet) | Surgery at 12 wk post-induction; days 14 and 28 post-surgery. | Smaller cellular and fibrous repair tissue was observed at the injury site of diabetic tendons relative to non-diabetic tendons. The degree of collagen remodeling and fiber alignment in the injured area was less in the diabetic tendons. | David et al[32], 2014 |
SD rats | Patellar tendons | CG and DG | At 1, 2, and 4 wk post-induction. | Disordered arrangement of collagen fibers, micro-tears, red blood cells and small blood vessels, and the rounding changed tendon cells surrounding the tear sites were observed in the diabetic tendons. IHC staining of diabetic patellar tendons showed increased expression of osteo-chondrogenic differentiation markers including OPN, OCN, SOX9, and Col II, and reduced expression of tenogenic markers including Col I and TNMD. | Shi et al[40], 2019 |
SD rats | Achilles tendons | CG and DG | At 6 wk post-induction | No significant difference was observed in fibre structure, fibre arrangement, rounding of the nuclei, and regional variations in cellularity between diabetic and non-diabetic Achilles tendons. Immunohistochemical staining of the diabetic Achilles tendon showed markedly increased NOX1 expression within the tenocytes compared with the non-diabetic tendons. | Ueda et al[42], 2018 |
SD rats | Achilles tendons | CG and DG | DM for over 1 year post-induction | IHC: Increased PPARγ-positive, rounded cells were found to reside in the diabetic tendons, aligning along the collagen fibrils. | Wu et al[41], 2017 |
SD rats | Achilles tendons | CG, acute DG and chronic DG | 1 wk for acute DM, 10 wk for chronic DM. | Total cell density and Achilles tendon cell proliferation were greater in the chronic diabetic tendons compared with the non-diabetic and acute diabetic tendons. | Volper et al[12], 2015 |
SD rats | Supraspinatus tendons | CG and hyperglycemia group | 8 wk following hyperglycemia induction | Cell shape at the insertion site and mid-substance of the hyperglycemic tendon did not alter, nor did cell density at the insertion site; however, the hyperglycemic tendon had a greater cell density at the mid-substance of the tendon compared to the non-hyperglycemic group. Immunohistochemistry staining of the tendon demonstrated significantly increased IL1-β and AGE staining localized to the insertion and mid-substance of the hyperglycemic tendon. | Thomas et al[35], 2014 |
Wistar rats | Achilles tendons | CG and DG | DM for 24 d post-induction | Tendon thickness, the density of fibrocytes and total cellularity, blood vessels and mast cells were significantly increased in diabetic tendons compared with non-diabetic tendons. IHC showed increased density of type I collagen, associated with the disorganization of the fibers in the diabetic tendons, and expression of VEGF and NF-κB. | de Oliveira et al[37], 2013 |
Male diabetic GK rats and Wistar control rats | Achilles tendons | CG and DG | DM for 1 yr | Diabetic tendons exhibited slightly lesser transverse area, but showed no apparent alteration in structural organization of collagen fibers. | Ahmed et al[21], 2012 |
Male white rats | Achilles tendons | CG and DG | Surgery at two weeks post-induction; four weeks post-surgery. | Fibroblasts, capillary and collagen were reduced during the healing process of diabetic tendons after transection injury. | Sananta et al[44], 2019 |
Wistar rats | Achilles tendons | CG and DG | Surgery at one-week post-induction; 21 d post-surgery. | The fibroblasts in injured diabetic tendons were significantly increased. IHC of the injured diabetic Achilles tendons showed nearly no Col I expression in comparison with injured non-diabetic tendons. | de Oliveira et al[36], 2019 |
Wistar rats | Achilles tendons | CG (low fat diet) and DG (high fat diet) | Surgery at 30 d post-induction; days 5, 10 and 15 post-surgery. | The diabetic tendons displayed a significant increase in inflammation and a significant decrease in fibrosis compared to the non-diabetic tendons. | Mohsenifar et al[20], 2014 |
Male GK rats and control Wistar rats | Achilles tendons | CG and DG | DM for one year; two weeks post-surgery. | After rupture, the diabetic tendons had a reduced reparative activity with decreased transverse area, poor structural organization and decreased vascularity. IHC of injured diabetic tendons showed weaker VEGF, Tβ-4, TGF-β1 and IGF-1immunoreactivity and fewer positively stained tenocytes, but strong COX-2, HIF-1α, iNOS and IL-1β at the injured site compared with injured non-diabetic tendons. | Ahmed et al[45], 2014 |
Male GK rats and control Wistar rats | Achilles tendons | CG and DG | DM for one year; two weeks post-surgery. | After rupture, the diabetic tendons had a reduced reparative activity illustrated by a much smaller transverse area, poor structural organization with fewer longitudinally oriented collagen fibers along the functional loading axis, and decreased vascularity, compared with injured non-diabetic tendons. Most fibers were yellowish and arranged irregularly, denoting ruptured Col I structures. IHC showed that less Col I, Collagen III and biglycan were observed, but increased MMP-13 around blood vessels and cells in the callus in the healing diabetic tendons. | Ahmed et al[21], 2012 |
Wistar Albino rats | Achilles tendons | CG and DG | Surgery at 3 d post-induction; 2-, 4- and 6-wk post-surgery. | Although similar collagen deposition and vessels proliferation were observed in both injured diabetic and non-diabetic tendons during healing, the injured diabetic tendons exhibited a significantly smaller amount of fibroblast proliferation and lymphocyte infiltration, and osteochondroid metaplasia of some tenocytes. | Egemen et al[43], 2012 |
Cell type | Cell source | Study type | Groups | Main results | Ref. |
Tendon-derived fibroblasts | SD rat, Achilles tendon | In vitro | NG (5.5 mmol/L) and HG (25 mmol/L) with different concentrations of AGEs (0, 50, 100, and 200 μg/mL). | HG had no effect on cell proliferation and expressions of genes associated with extracellular matrix remodeling. AGEs impaired proliferative capacity, ATP production, and electron transport chain efficiency, coupled with alterations in mitochondrial DNA content and expression of genes associated with extracellular matrix remodeling, mitochondrial energy metabolism, and apoptosis. While HG condition did impact some mitochondrial parameters, AGEs appear to be the primary insult and may be responsible for the development of the diabetic tendon phenotype. | Patel et al[51], 2019 |
Tenocytes | SD rat, Achilles tendon | In vitro and in vivo | CG (12 mmol/L) and HG (33 mmol/L) | Significantly higher gene expressions of NOX1, NOX4, MMP-2, TIMP-1, TIMP-2, IL-6, Col III and ROS accumulation but lower cell proliferation and type I collagen expression in HG than those in CG. | Ueda et al[42], 2018 |
Tenocytes | SD rat, Achilles tendon | In vitro | LG (5.5 mmol/L) and HG (25 mmol/L) | High glucose-treated tenocytes expressed higher levels of the adipogenic transcription factors PPARγ and C/EBPs. Increased adipogenic trans-differentiation and decreased cell migration induced by high glucose. | Wu et al[41], 2017 |
Tenocytes | SD rat, Achilles tendon | In vitro | LG (5.5 mmol/L) and HG (25 mmol/L) | No significant effect on cell growth and apoptosis between LG and HG. Increased glucose uptake and consumption in HG condition. Significantly decreased expression of tendon-related genes, including Egr1, Mkx, TGF-β1, Col1a2, and Bgn, in HG culture. | Wu, et al[39], 2017 |
Tenocytes | Human, hamstring tendon | In vitro | LG (5 mmol/L) and HG (17.5 mmol/L) | Apoptosis level of tenocytes was 1.5 times greater in peroxide-treated cells cultured in HG compared with untreated controls, while apoptosis level of tenocytes was not increased in peroxide-treated cells cultured in low glucose. Peroxide-treated tenocytes cultured in low glucose expressed higher RNA levels of col1a1 and col1a2. | Poulsen, et al[57], 2014 |
Tenocytes | SD rat, Achilles tendon. | In vitro | LG (6 mmol/L) and HG (12 mmol/L and 25 mmol/L) | The glucose concentration did not affect tendon cell proliferation. The mRNA expression of MMP-9 and MMP-13 was up-regulated by treatment with 25 mmol/L glucose, whereas the mRNA expression of type I and III collagen was not affected. 25 mmol/L glucose increased the enzymatic activity of MMP-9. | Tsai et al[50], 2013 |
Tenocytes | Porcine, patellar tendon. | In vitro | LG (5.5 mmol/L) and HG (25 mmol/L) | Exposure to HG or AGEs did not affect cell viability. Significantly decreased PG levels in tendons exposed to HG. Relative mRNA levels of biglycan and veriscan were unchanged in HG. Levels of fibromodulin were modestly increased, whereas mRNA for decorin and lumican were significantly decreased. High glucose media decreased PG production by tenocytes whereas AGE-modified type I collagen and free radical scavengers had no effects. High glucose conditions increase TGFβ1 levels in tenocyte. | Burner et al[52], 2012 |
Tenocytes | Porcmine, patellar tendon | In vitro | NG (5.5 mmol/L) and HG (25 mmol/L) | Significantly higher Tgase activity in tenocytes incubated in HG. CML-Collagen stimulated Tgase activity in tenocytes in both normal and high glucose media but did not induce markers of apoptosis or alter cell viability. Antioxidants reduced the effect of CML-Collagen on tenocytes Tgase activity. | Rosenthal et al[58], 2009 |
TDSCs | Human, patellar tendon, rotator cuff and hamstring tendons. | In vitro | LG (5.5 mmol/L) and HG (11.1 mmol/L) | HG stimulated inflammation and weakened pro-resolving inflammation response in TDSCs. | Kwan et al[87], 2020 |
TDSCs | SD rats, Achilles tendon | In vitro and in vivo | CG and AGEs-treated group | AGEs decreased the cell viability, induced apoptosis and senescence of TDSCs, exacerbated osteogenic differentiation of TDSCs and led to more ectopic calcification in Achilles tendon. | Xu et al[83], 2020 |
TPCs | Horses, superficial digital flexor tendons | In vitro | CG and insulin-treated group (insulin concentrations: 0, 0.07, 0.7 nmol/L) | Insulin increased proliferation and osteogenic differentiation of TPCs in vitro, with the increased ALP activity and elevated expression of osteogenic genes including Runx2, ALP and osteonection. | Durgam et al[84] 2019 |
TDSCs | SD rats, patellar tendon | In vitro | Non-diabetic TDSCs and diabetic TDSCs | Significantly decreased colony-forming ability, cell proliferation and tenogenic differentiation ability and increased osteogenic and chondrogenic differentiation ability were demonstrated in diabetic TDSCs. | Shi et al[40], 2019 |
TDSCs | SD rats, patellar tendon | In vitro | LG (5.5 mmol/L) and HG (15 mmol/L, 25 mmol/L) | High glucose could inhibit proliferation, induce cell apoptosis and suppress the tendon-related markers expression of TDSCs. | Lin et al[82], 2017 |
- Citation: Lu PP, Chen MH, Dai GC, Li YJ, Shi L, Rui YF. Understanding cellular and molecular mechanisms of pathogenesis of diabetic tendinopathy. World J Stem Cells 2020; 12(11): 1255-1275
- URL: https://www.wjgnet.com/1948-0210/full/v12/i11/1255.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i11.1255